Thus we hypothesized that the upregulated hepatic Cyp3a and SLCO1B1 by diabetes may increase atorvastatin uptake and metabolism leading to massive ROS formation, which resulted in the enhanced atorvastatin-induced hepatotoxicity in diabetic rats. The gene discussed is CYP3A4; the disease is diabetes mellitus.